More Promising Data on Stem Cell Transplant for MS – Medscape
|
More Promising Data on Stem Cell Transplant for MS
Medscape Autologous hematopoietic stem cell transplant (AHSCT) proved "unequivocally" superior to mitoxantrone in reducing imaging evidence of disease activity in patients with multiple sclerosis (MS) refractory to conventional therapy in a phase 2 randomized … |
